Minerva Neurosciences (NERV) News Today → Does this make you sick? (From Allegiance Gold) (Ad) Free NERV Stock Alerts $2.50 -0.02 (-0.79%) (As of 12:47 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 3:50 AM | americanbankingnews.comStockNews.com Begins Coverage on Minerva Neurosciences (NASDAQ:NERV)May 10, 2024 | americanbankingnews.comMinerva Neurosciences (NASDAQ:NERV) Downgraded to Sell at StockNews.comMay 1, 2024 | finanznachrichten.deMinerva Neurosciences, Inc: Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business UpdatesMay 1, 2024 | chron.comMinerva Neurosciences: Q1 Earnings SnapshotMay 1, 2024 | markets.businessinsider.comMinerva Neurosciences Reports First Quarter 2024 Financial Results and Business UpdatesMay 1, 2024 | globenewswire.comMinerva Neurosciences Reports First Quarter 2024 Financial Results and Business UpdatesApril 29, 2024 | msn.comUnique Far North steam experience closer after new boiler arrives for SS MinervaApril 27, 2024 | yahoo.comAlliance Elks announce teens of month for AprilApril 20, 2024 | msn.comPolice: 3 injured in Minerva Park single-vehicle crashApril 20, 2024 | msn.comOff-duty firefighters & neighbor rescue baby, residents from burning Minerva houseApril 4, 2024 | msn.comPrairie voles display signs of human-like depression, show promise as animal modelMarch 31, 2024 | msn.comNew track and field season gives Minerva sprinter Kyleigh Lippincott a fresh startMarch 14, 2024 | msn.comPotts Point homelessness encampment moved on from Minerva-Metro Theatre siteMarch 14, 2024 | tmcnet.comMinerva Named "One to Watch" in Chartis Financial Crime and Compliance 50 RankingsMarch 13, 2024 | msn.comRenovated Manti Temple, preserved Minerva Teichert murals ready for 3-week public open houseMarch 13, 2024 | tmcnet.comMinerva Named Top AI & Data Product in the 2024 Product AwardsFebruary 27, 2024 | markets.businessinsider.comHold Rating on Minerva Neurosciences Amid FDA Setbacks and Financial ConstraintsFebruary 27, 2024 | finance.yahoo.comMinerva schizophrenia drug rejected by FDAFebruary 27, 2024 | marketwatch.comFDA Turns Away Minerva's Roluperidone Schizophrenia DrugFebruary 27, 2024 | morningstar.comMinerva Neurosciences Shares Slide on Latest FDA Roluperidone SetbackFebruary 27, 2024 | msn.comRegulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More DataFebruary 27, 2024 | msn.comMinerva falls as FDA rejects schizophrenia therapyFebruary 27, 2024 | bizjournals.comFDA rejects Burlington biotech’s schizophrenia drug, sends stock tumblingFebruary 27, 2024 | marketbeat.comTrading was temporarily halted for "NERV" at 09:02 AM with a stated reason of "LULD pause."February 27, 2024 | reuters.comUS FDA declines to approve Minerva Neurosciences' schizophrenia drugFebruary 27, 2024 | finance.yahoo.comMinerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with SchizophreniaFebruary 27, 2024 | marketbeat.comTrading was temporarily halted for "NERV" at 07:02 AM with a stated reason of "News pending."February 25, 2024 | msn.comREUTERS NEWS SCHEDULE AT 7:00 a.m. SGT /6:00 p.m. ETFebruary 22, 2024 | benzinga.com2NERV : Minerva Neurosciences: Q4 Earnings InsightsFebruary 22, 2024 | sfgate.comMinerva Neurosciences: Q4 Earnings SnapshotFebruary 22, 2024 | finance.yahoo.comMinerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business UpdatesFebruary 22, 2024 | globenewswire.comMinerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business UpdatesFebruary 9, 2024 | seekingalpha.comSUNW, NSTG and NERV among mid-day moversFebruary 7, 2024 | msn.comMarket Street Art Spot expands gallery and marks 13th anniversary in MinervaFebruary 2, 2024 | marketbeat.comMinerva Neurosciences (NASDAQ:NERV) Stock Passes Above 50-Day Moving Average of $6.77Minerva Neurosciences (NASDAQ:NERV) Stock Price Passes Above 50-Day Moving Average of $6.77February 2, 2024 | marketbeat.comMinerva Neurosciences (NASDAQ:NERV) Stock Rating Lowered by StockNews.comStockNews.com cut Minerva Neurosciences from a "hold" rating to a "sell" rating in a research note on Friday.January 31, 2024 | msn.comGarth Evans set to become Minerva Local Schools' next athletic directorJanuary 17, 2024 | msn.com'His fight is our fight': Malvern, Minerva basketball players learn life lessonJanuary 16, 2024 | finance.yahoo.comMinerva Announces Channel Partner Program to Broaden the Reach of its AML Risk Assessment SolutionJanuary 14, 2024 | news.yahoo.comEducation roundup: Minerva teacher is American Legion Educator of the YearDecember 8, 2023 | morningstar.comMinerva Neurosciences Inc NERVNovember 7, 2023 | markets.businessinsider.comMinerva Neurosciences Reports 2023 Third Quarter Financial Results and Business UpdatesNovember 7, 2023 | msn.comMinerva Neurosciences GAAP EPS of -$1.03 misses by $0.26November 7, 2023 | finance.yahoo.comMinerva Neurosciences Reports 2023 Third Quarter Financial Results and Business UpdatesOctober 17, 2023 | msn.comMeetings set on Minerva-Johnsburg school mergerOctober 13, 2023 | news.yahoo.comFirefighters battle railroad ties fire for 17+ hours just outside MinervaOctober 11, 2023 | msn.comHoming in on the importance of diversity in researchOctober 7, 2023 | msn.comMarlington High School football scores on first 5 possessions, routs MinervaOctober 6, 2023 | benzinga.comCEO at Minerva Neurosciences Acquires Company Stock Options Worth 100,450 SharesOctober 6, 2023 | benzinga.comPresident at Minerva Neurosciences Acquires Company Stock Options Worth 87,050 Shares Get Minerva Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NERV and its competitors with MarketBeat's FREE daily newsletter. Email Address Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some NERV Media Mentions By Week NERV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NERV News Sentiment▼0.000.42▲Average Medical News Sentiment NERV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NERV Articles This Week▼11▲NERV Articles Average Week Get Minerva Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NERV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Talphera News GlycoMimetics News Flora Growth News VBI Vaccines News Vincerx Pharma News Galecto News Aytu BioPharma News Sol-Gel Technologies News Indaptus Therapeutics News Cocrystal Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NERV) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestObama’s Forever Term [exposed]Porter & CompanyNew Options need New Trading StrategiesNetpicks Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
